InnoCare Pharma Limited
INCPF · OTC
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | August 25, 2026 | — | 22.31M | — | -0.01 | — |
| 2026 Q1 | April 23, 2026 | 76.61M | 14.11M | 0.01 | -0.03 | — |
| 2025 Q4 | March 25, 2026 | 177.43M | 99.14M | 0.06 | — | — |
| 2025 Q3 | November 14, 2025 | 53.91M | 382.61M | 0.00 | — | — |
| 2025 Q2 | August 19, 2025 | 48.84M | 185.50M | -0.01 | — | — |
| 2025 Q1 | May 13, 2025 | 52.52M | — | 0.00 | — | — |
| 2024 Q4 | March 27, 2025 | 42.73M | — | -0.01 | — | — |
| 2024 Q3 | November 11, 2024 | 39.61M | — | 0.00 | — | — |
| 2024 H1 | August 21, 2024 | 34.94M | — | -0.01 | — | — |
| 2024 Q1 | May 13, 2024 | 22.96M | — | -0.01 | — | — |
| 2023 H2 | March 28, 2024 | 28.40M | — | -0.01 | -0.03 | — |
| 2023 Q3 | November 13, 2023 | 21.88M | — | -0.01 | — | — |
| 2023 H1 | August 30, 2023 | 25.92M | — | -0.03 | -0.03 | — |
| 2023 Q1 | May 9, 2023 | 27.57M | — | 0.00 | — | — |
| 2022 H2 | March 27, 2023 | — | — | — | — | — |
| 2022 Q3 | November 13, 2022 | 27.50M | 22.31M | -0.04 | -0.01 | — |